| Literature DB >> 35146703 |
Antonio Granato1, Giovanni Furlanis1, Laura D'Acunto1, Sasha Olivo1, Alex Buoite Stella1, Paolo Manganotti2.
Abstract
BACKGROUND: The COVID-19 lockdown has influenced people lifestyle, behaviour, physical activity (PA), and working habits as well as, possibly, migraine. The aim of the study was to assess the impact of lockdown on the burden of migraine attacks during COVID-19 lockdown.Entities:
Keywords: COVID-19; Headache; Home confinement; Lifestyle; Lockdown; Migraine
Mesh:
Year: 2022 PMID: 35146703 PMCID: PMC8831145 DOI: 10.1007/s13760-021-01856-2
Source DB: PubMed Journal: Acta Neurol Belg ISSN: 0300-9009 Impact factor: 2.396
Participants’ demographics. Data are presented as medians (interquartile range) and frequencies
| Personal characteristics | MwoA | MwA + MwA/MwoA |
|---|---|---|
| Age [y] | 45 (31–53) | 38 (26–47) |
| Females [ | 23 (88) | 7 (64) |
| BMI [kg/m2] | 24 (18–32) | 27 (18–50) |
| Habitation [ | ||
| Urban area | 20 (77) | 9 (82) |
| Town/rural area | 6 (23) | 2 (18) |
| House | 9 (35) | 4 (36) |
| Apartment | 17 (65) | 7 (64) |
| Garden/Roof | 17 (65) | 5 (45) |
| Size of the house [m2] | 94 (40–250) | 85 (60–150) |
| ≥ 90 m2 [ | 13 (50) | 4 (36) |
| < 90 m2 [ | 13 (50) | 7 (64) |
| Occupation [ | ||
| Occupied | 19 (73) | 11 (100) |
| Manager | 2 (8) | 1 (9) |
| Employee | 10 (38) | 5 (45) |
| Worker | 2 (8) | 2 (19) |
| Freelance | 5 (19) | 3(27) |
| Non occupied/Retired/Student | 7 (27) | 0 (0) |
| Occupation during lockdown | ||
| Unchanged | 7 (27) | 2 (19) |
| Suspended | 6 (23) | 4 (36) |
| Smart-working | 6 (23) | 5 (45) |
| Training [days/week] | 0 (0–1) | 0 (0–2) |
| Structured PA [ | 6 (23) | 4 (36) |
| Food habits lockdown [ | ||
| More than usual | 9 (35) | 5 (45) |
| Same as usual | 12 (46) | 6 (55) |
| Less than usual | 5 (19) | 0 |
MwoA migraine without aura; MwA migraine with aura; BMI Body Mass Index; PA Physical Activity
Participants’ characteristics during the reference month (January) and during the lockdown (April). Data are presented as medians [interquartile range] and frequencies
| Personal Characteristics | MwoA | MwA + MwA/MwoA | ||||
|---|---|---|---|---|---|---|
| Reference | Lockdown | Sig | Reference | Lockdown | Sig | |
| Sleep | ||||||
| Duration [h] | 7 (6–8) | 7 (6–8) | 0.267 | 6 (6–8) | 7 (6–8) | 0.450 |
| Quality [ | 0.453 | 1.000 | ||||
| Poor | 0 | 0 | 0 | 0 | ||
| Fair | 5 (19) | 8 (31) | 2 (18) | 1 (10) | ||
| Not bad nor good | 10 (38) | 5 (19) | 4 (36) | 1 (10) | ||
| Good | 10 (39) | 11 (42) | 4 (36) | 5 (45) | ||
| Excellent | 1 (4) | 2 (8) | 1 (10) | 4 (35) | ||
| Daily Fluid Intake [mL] | 1500 (1000–2000) | 1500 (1100–2000) | 0.590 | 1500 (1125–2250) | 1500 (1125–1875) | 0.892 |
| Coffee [ | 2 (1–3) | 1 (1–2) | 0.048 | 3.5 (2–5) | 3.5 (2–5) | 1.000 |
| Smokers [ | 8 (31) | 7 (27) | 1.000 | 4 (36) | 4 (36) | 1.000 |
| Cigarettes [ | 5 (3–10) | 5 (3–8) | 0.317 | 8 (4–18) | 12 (4–20) | 0.317 |
| Usual alcohol consumers [ | 15 (58) | 12 (46) | 0.375 | 9 (82) | 7 (73) | 1.000 |
| Wine/beer [U/week] | 1 (0–1) | 0 (0–1) | 0.084 | 1 (0–1) | 1 (0–1) | 0.705 |
| Spirits [U/week] | 0 (0–0) | 0 (0–0) | 0.317 | 0 (0–0) | 0 (0–0) | 0.317 |
| Work | ||||||
| Work at the workplace [h/day] | 8 (5–8) | 0 (0–6) | 6 (5–8) | 0 (0–0) | ||
| Screen use at the workplace [h/day] | 1 (0–6) | 0 (0–0) | 3 (0–8) | 0 (0–0) | ||
| Remote working at home [h/day] | 0 (0–0) | 0 (0–6) | 0 (0–0) | 0 (0–8) | 0.039 | |
| Screen use remote working at home [h/day] | 0 (0–0) | 0 (0–6) | 0 (0–0) | 0 (0–8) | 0.039 | |
| Overall screen use [h/day] | 0 (0–6) | 0 (0–6) | 1.000 | 3 (0–8) | 0 (0–8) | 0.465 |
| Daily Steps Count [count] | 10,000 (7000–12,000) | 2000 (1000–2000) | 8000 (5250–13,750) | 2000 (1250–2000) | 0.068 | |
| IPAQ-SF (MET) | 792 (531–1950) | 273 (82–816) | 1356 (495–2142) | 426 (66–2209) | 0.074 | |
| Insufficient MET levels [ | 8 (31) | 17 (65) | 5 (45) | 7 (64) | 0.625 | |
| Headache | ||||||
| Total headache days [count] | 4 (3–8) | 3 (1–6) | 0.521 | 2 (1–4) | 2 (1–5) | 0.757 |
| Severe headache days | 2 (1–3) | 1 (0–3) | 0.376 | 1 (0–2) | 1 (0–2) | 0.762 |
| Duration of attack (h) | 3 (2–12) | 2 (1–8) | 0.041 | 2 (1–2) | 2 (1–2) | 0.893 |
| Symptomatic drugs | 3 (1–4) | 2 (1–4) | 0.812 | 2 (0–3) | 1 (1–5) | 0.676 |
| HIT-6 | 59 (51–63) | 50 (44–57) | 56 (49–60) | 45 (36–49) | 0.062 | |
| Pain free after SDI [ | 13 (50) | 20 (77) | 0.070 | 3 (27) | 5 (45) | 1.000 |
MwoA migraine without aura; MwA migraine with aura; IPAQ-SF International Physical Activity Questionnaire-Short Form; MET metabolic equivalents; HIT Headache Impact Test. SDI symptomatic drug intake. Significance value (Sig.) for reference-lockdown comparison. Bold values for comparisons remaining significant after Bonferroni correction for multiple testing